To mix or not to mix in lupus anticoagulant testing? That is the question

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 4, 2012, Pages 385-389

  Tripodi, Armando ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

anticoagulant testing; coagulation; lupus like anticoagulants; mixing tests

Indexed keywords

LUPUS ANTICOAGULANT;

ARTICLE; BLOOD CLOTTING TEST; DILUTION; FALSE NEGATIVE RESULT; HUMAN; PLASMA CHARACTERISTICS; PRIORITY JOURNAL;

ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; FEMALE; HUMANS; IMMUNOGLOBULINS; LUPUS COAGULATION INHIBITOR; PREGNANCY;

EID: 84861343727     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1304717     Document Type: Article

References (22)

1. Margolius A Jr, Jackson DP, Ratnoff OD. Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine (Baltimore): 1961; 40 145 202
2. Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest: 1952; 31 621 622
3. Bowie EJ, Thompson JH Jr, Pascuzzi CA, Owen CA Jr. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med: 1963; 62 416 430
4. Rai RS, Regan L, Clifford K., et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod: 1995; 10 8 2001 2005
5. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost: 1995; 74 4 1185 1190
6. Pengo V, Tripodi A, Reber G., et al. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost: 2009; 7 10 1737 1740
7. Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost: 1987; 57 2 144 147 (Pubitemid 18024502)
8. Chang SH, Tillema V, Scherr DA. A "percent correctiono" formula for evaluation of mixing studies. Am J Clin Pathol: 2002; 117 1 62 73 (Pubitemid 34052474)
9. Devreese KM. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants. Thromb Res: 2007; 119 3 369 376 (Pubitemid 44918102)
10. Moore GW, Savidge GF. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res: 2006; 118 4 523 528 (Pubitemid 44292799)
11. Moore GW, Henley A, Greenwood CK, Rangarajan S. Further evidence of false negative screening for lupus anticoagulants. Thromb Res: 2008; 121 4 477 484 (Pubitemid 351174269)
12. Thom J, Ivey L, Eikelboom J. Normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulant. J Thromb Haemost: 2003; 1 12 2689 2691
13. Kaczor DA, Bickford NN, Triplett DA. Evaluation of different mixing study reagents and dilution effect in lupus anticoagulant testing. Am J Clin Pathol: 1991; 95 3 408 411
14. Devreese KM. No more mixing tests required for integrated assay systems in the laboratory diagnosis of lupus anticoagulants? J Thromb Haemost: 2010; 8 5 1120 1122
15. Favaloro EJ, Bonar R, Zebeljan D, Kershaw G, Marsden K. Laboratory investigation of lupus anticoagulants: mixing studies are sometimes required. J Thromb Haemost: 2010; 8 12 2828 2831
16. Bonar R, Favaloro EJ, Zebeljan D., et al. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP. Pathology: 2012; 44 3 240 247
17. Chantarangkul V, Tripodi A, Arbini A, Mannucci PM. Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants. Thromb Res: 1992; 67 4 355 365
18. Triplett DA, Barna LK, Unger GA. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost: 1993; 70 5 787 793 (Pubitemid 23339454)
19. Loeliger A. Prothrombin as cofactor of circulating anticoagulant in systemic lupus crythematosus. Thromb Diath Haemorrh: 1959; 3 237 256
20. Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood: 1976; 48 4 499 509
21. Yin ET, Gaston LW. Purification and kinetic studies on a circulating anticoagulant in a suspected case of lupus erythematosus. Thromb Diath Haemorrh: 1965; 14 1-2 88 115
22. Oosting JD, Derksen RH, Entjes HT, Bouma BN, de Groot PG. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I. Thromb Haemost: 1992; 67 5 499 502